Press Releases

IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time). A live audio webcast of the presentation will be available on the Company's website in the "Investors—Events & Presentations" section at https://investors.betabionics.com, and will be archived there for future replay following the event. About Beta Bionics Beta Bionics, Inc. is a commercial-stage medical device company engaged in the des

Commerce Bancshares, Inc. (NASDAQ:CBSH) announced today that it has participated in an exchange offer initiated by Visa Inc. ("Visa") involving a portion of the Company's Visa Class B‑2 common stock holdings. Under the terms of the exchange offer, and subject to final settlement, Commerce expects to exchange tendered Visa Class B‑2 shares for a combination of Visa Class B-3 common stock and Visa Class C common stock. The Company has tendered all 411,723 of its shares of Visa Inc. Class B-2 common stock and is awaiting notification of acceptance of that tender and the closing of the exchange offer. If the Company's tendered shares are accepted and the exchange occurs in the second quarte

Millicom (Tigo) strengthens its position in Colombia following the successful acquisition of the government stake in Coltel This milestone enhances scale and investment capacity to strengthen network capabilities and support future growth in Colombia. Luxembourg, April 27, 2026 – Millicom International Cellular S.A. ("Millicom") today announced it has acquired the remaining 32.5% equity stake in Colombia Telecomunicaciones S.A. E.S.P. ("Coltel") formerly held by La Nación. This milestone follows the successful conclusion of the tender offer for Telefónica's controlling stake in February 2026 and marks the final step in Millicom's strategic consolidation of the entity. The acquisition rep

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Prospect Enhanced Yield Fund ("PENF" or the "Fund") announced today that the Fund's Board of Directors has declared monthly cash shareholder distributions for April 2026, May 2026, and June 2026. These distributions represent the seventh, eighth, and nineth monthly distributions paid by the Fund. The annualized total cash distribution is $2.28 per share (9.33% annualized rate based on the April 19, 2026 net asset value), for distributions with record dates between April 29, 2026 and June 29, 2026 based on the current net asset value of $24.44 per common share. The cash distribution will have monthly record dates and will be payable monthly to

Jamie Dimon, Chairman and Chief Executive Officer of JPMorganChase, will present at the Bernstein Strategic Decisions Conference in New York City on Wednesday, May 27, 2026, at 9:00 a.m. (Eastern). A live audio webcast will be available on the day of the conference at www.jpmorganchase.com under Investor Relations, Events & Presentations. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorgan Chase had $4.9 trillion in assets and $364 billion in stockholders' equity as of March 31, 2026. The Firm is a leader in investment banking, financial services for consumers and small businesses, comme

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the first quarter 2026 on Thursday, May 14, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Invest

SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here. About Trupanion Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, and certain countries in Continental Europe with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the highest value i

TORONTO, April 27, 2026 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV:MOON; NASDAQ: BMM), (TSXV: MOON; NASDAQ:BMM), is pleased to announce its board of directors has approved a final investment decision on the construction for its Nussir project ("Project"), located in northern Norway. The recent Feasibility Study on the Project announced on April 16, 2026, highlighted a 13-year mine life with a nominal 6,000 tonne per day underground mine and processing facility with ore production starting in Q3-2027. Furthermore, recently announced exploration success at the Project (see release dated April 15, 2026), highlights the potential upside and longevity of the

Consolidated Results of Operations - Three-Month Periods Ended March 31, 2026 and 2025:KING OF PRUSSIA, Pa., April 27, 2026 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended March 31, 2026, net income was $5.0 million, or $.36 per diluted share, as compared to $4.8 million, or $.34 per diluted share, during the first quarter of 2025. The increase in our net income of $242,000, or $.02 per diluted share, during the three-month period ended March 31, 2026, as compared to the first quarter of 2025, consisted of the following: (i) an increase of $217,000, or $.02 per diluted share, resulting from a decrease in interest expense d

Quarterly earnings of $0.88 per share Quarterly return on average assets of 1.58% Robust net interest margin of 4.26%; Core adjusted of 4.08% Low efficiency ratio* of 51.2% Healthy credit metrics with annualized net charge-offs of 0.08% and non-performing assets of 0.35% to total assets Healthy level of non-interest bearing demand accounts representing 28% of total deposits Tangible common equity* ("TCE") ratio increased to 9.6%; Return on average TCE* ("ROATCE") of 17.08% 21+ years of double digit return on average shareholders' equity 7% cash dividend increase announced in January 2026, making it the 14th consecutive year of increased cash dividends Heartland B

Booz Allen Hamilton (NYSE:BAH) today announced senior leadership appointments that strengthen the company's position as an advanced technology provider for U.S. federal and global commercial markets. Effective May 4, 2026, Troy Lahr has been appointed Executive Vice President and Chief Financial Officer. Lahr brings more than 25 years of financial and business leadership experience for both commercial tech and defense companies. As CFO he will oversee the company's fiscal performance, capital structure, mergers and acquisitions, and related financial operations, reporting directly to Chairman of the Board and Chief Executive Officer Horacio Rozanski. Lahr was most recently CFO at Sierra

MENLO PARK, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (NASDAQ:ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications, today announced that it has commenced an underwritten public offering of $500 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. In addition, Oruka expects to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of its common stock at the public offering price, less underwriting discounts and co

EPS of $0.34 FFO per Share, As Adjusted for Comparability, of $0.69 6.2% FFO per Share Growth Year-over-Year 1-cent above the Midpoint of Guidance Increased Midpoint of 2026 FFO per Share Guidance by 1-cent to $2.76 Implies 1.5% FFO per Share Growth for the Year Same Property Cash NOI Increased 5.4% Increased Midpoint of 2026 Guidance by 50 basis points to 3.0% Occupancy and Leased Levels Total Portfolio 94.4% Occupied and 95.2% Leased Defense/IT Portfolio 95.6% Occupied and 96.4% Leased Leasing Activity Total Leasing of 1.6 million SF Vacancy Leasing of 92,000 SF On Track to Achieve Annual Target of 400,000 SF Renewal Leasing of 1.2 million SF Tenant Retenti

PORTLAND, Maine, April 27, 2026 (GLOBE NEWSWIRE) -- Northeast Bank (the "Bank") (NASDAQ:NBN), a Maine-based bank, today reported net income of $29.9 million, or $3.53 per diluted common share, for the quarter ended March 31, 2026, compared to net income of $18.7 million, or $2.23 per diluted common share, for the quarter ended March 31, 2025. Net income for the nine months ended March 31, 2026 was $73.1 million, or $8.67 per diluted common share, compared to $58.2 million, or $7.07 per diluted common share, for the nine months ended March 31, 2025. The Board of Directors declared a cash dividend of $0.01 per share, payable on May 26, 2026, to shareholders of record as of May 12, 2026. "

Valmont® Industries, Inc. (NYSE:VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today announced that its Board of Directors has declared a quarterly dividend of $0.77 per share payable on July 15, 2026, to shareholders of record on June 26, 2026. The dividend indicates an annual rate of $3.08 per share. About Valmont Industries, Inc. For more than 80 years, Valmont has been a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity. We are committed to customer-focused innovation that delivers lasting value. Learn more about how we're Conservi

Sample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration testing demand QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced preliminary results for the first quarter of 2026, continuing to deliver strong profitability as adjusted diluted earnings per share (EPS) achieved the outlook. Sales trends were mixed, as lower QuantiFERON sales and cautious U.S. Life Sciences customer demand offset solid growth in other areas of the portfolio. For Q1 2026, preliminary net sales were $492 million, up 2% on a reported basis and down 1% at constant exchange rates (CER) compared with the outlook for at least 1% CER g

Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended March 31, 2026 and 2025:KING OF PRUSSIA, Pa., April 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) announced today that its reported net income attributable to UHS was $348.7 million, or $5.65 per diluted share, during the first quarter of 2026, as compared to $316.7 million, or $4.80 per diluted share, during the first quarter of 2025.  Net revenues increased by 9.6% to $4.495 billion during the first quarter of 2026, as compared to $4.100 billion during the first quarter of 2025. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our ad

2026 First Quarter HighlightsNet sales of $588.0 million increased 9.1% year-over-yearIncome from operations of $114.6 million increased 12.0% year-over-yearNet income per diluted share of $2.13 increased 15.1% year-over-yearRepurchased $50.0 million of common stock during the quarterPLEASANTON, Calif., April 27, 2026 /PRNewswire/ -- Simpson Manufacturing Co., Inc. (the "Company") (NYSE:SSD), an industry leader in engineered structural connectors and building solutions, today announced its financial results for the first quarter of 2026. All comparisons below (which are generally indicated by words such as "increased," "decreased," "remained," or "compared to"), unless otherwise noted, are c

FRANKLIN LAKES, N.J., April 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 12, 2026 at 11:40 am Eastern Time. The live webcast of BD's presentation can be accessed from the BD investor relations website,  investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.About BDBD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems

Minority investment with path to full ownership underscores strong conviction in one of the category's largest segmentsLOS ANGELES, April 27, 2026 /PRNewswire/ -- Match Group (NASDAQ:MTCH) today announced a $100 million investment in Sniffies, a cruising map and fast-growing platform serving non-heterosexual men. The investment represents a significant minority ownership stake and includes the option to acquire the remaining equity in the future. This reflects Match Group's focus on backing platforms with strong product-market fit that are authentic to their audience. The compan